KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Acquisitions & Divestments (2016 - 2026)

Bio-Rad Laboratories has reported Change in Acquisitions & Divestments over the past 17 years, most recently at $17.7 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 9.23% to $17.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $60.2 million through Mar 2026, down 94.29% year-over-year, with the annual reading at $62.0 million for FY2025, 94.39% down from the prior year.
  • Change in Acquisitions & Divestments was $17.7 million for Q1 2026 at Bio-Rad Laboratories, up from -$584.2 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $601.0 million in Q3 2025 and troughed at -$584.2 million in Q4 2025.
  • The 5-year median for Change in Acquisitions & Divestments is $76.1 million (2023), against an average of $120.3 million.
  • Year-over-year, Change in Acquisitions & Divestments soared 12169.9% in 2022 and then plummeted 384.28% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $65.1 million in 2022, then soared by 150.28% to $162.9 million in 2023, then grew by 26.18% to $205.5 million in 2024, then plummeted by 384.28% to -$584.2 million in 2025, then soared by 103.03% to $17.7 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Change in Acquisitions & Divestments are $17.7 million (Q1 2026), -$584.2 million (Q4 2025), and $601.0 million (Q3 2025).